Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...
The i on MSN13h
‘Game-changing’ chronic and recurrent UTI drug to be rolled out across NHS in weeksGame-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic ...
The issues surrounding boarding homes made headlines this spring following the arrest of Regla Becquer, who ran homes in ...
Pregnancy is often a risky time for women, but in the U.S., a woman's pregnancy can ... as well as devices that monitored for postpartum bleeding, sepsis, urinary tract infections, anemia, and ...
Vaginoplasty is associated with a high incidence of postoperative UTI and SSI, as well as significant gaps in HIV screening and PrEP prescribing.
Women have a higher risk of heart failure and stroke than ... bringing the total number of infections in the country to four.
By starting with an idea that’s already been vetted or developed as a new product or service, entrepreneurs can focus on ...
A preterm birth is defined as a baby being born alive before 37 weeks of pregnancy are completed. The World Health ...
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback